title: Clinical presentations of thyroid cancer patients with multiple primary cancers.
abstract: BACKGROUND
  In thyroid cancer patients with multiple primary cancers, primary cancers tend to be more aggressive.
  
  
  OBJECTIVE
  We analyzed multiple primary cancers in thyroid cancer patients and determined the differences between the incidence and the characteristics of primary cancers.
  
  
  METHODS
  A total of 3070 patients with thyroid cancer underwent a thyroidectomy and follow-up examination at a single medical center. The times of diagnosis of the primary cancers were categorized as antecedent, synchronous, or subsequent to the diagnosis of thyroid cancer.
  
  
  RESULTS
  After a mean follow-up period of 8.8 ± 0.5 yr, the presence of multiple primary cancers was histopathologically confirmed in 163 patients (5.3%). Patients with multiple primary cancers had a lower female-to-male ratio, an older mean age, advanced tumor-node-metastasis (TNM) stage, higher total mortality, and higher therapeutic radioactive iodide (131I) doses than patients without multiple primary cancers. Hematological malignancy and renal cell carcinoma, neither of which are among the 10 most common cancers observed in the general population of Taiwan, were the most common multiple cancers among women and men with thyroid cancer. Patient age, thyroid cancer tumor size, and thyroid cancer mortality in the antecedent, synchronous, and subsequent groups were not significantly different.
  
  
  CONCLUSIONS
  Patients with multiple primary cancers in advanced stages had shorter disease-free survival period after treatment. Thyroid cancer patients with multiple primary cancers should be closely followed up for the occurrence of other secondary cancers in order to improve total mortality.
authors: Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, 5 Fu-Shin St Kweishan county, Taoyuan Hsien, Taiwan, Republic of China. einjd@adm.cgmh.org.tw
authors: J D
authors: JD
authors: Lin
authors: K J
authors: KJ
authors: Lin
authors: T C
authors: TC
authors: Chao
authors: C
authors: C
authors: Hseuh
authors: N M
authors: NM
authors: Tsang
authors: B Y
authors: BY
authors: Huang
references: Radiother Oncol. 2009 Apr;91(1):4-15; discussion 1-3
references: 19201045
references: Stat Med. 2002 Mar 15;21(5):701-15
references: 11870811
references: Clin Endocrinol (Oxf). 2006 Aug;65(2):229-33
references: 16886965
references: Arch Otolaryngol Head Neck Surg. 2009 Apr;135(4):355-9
references: 19380356
references: Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2647-55
references: 18843006
references: Eur J Cancer. 2001 Oct;37(15):1886-94
references: 11576845
references: Clin Nucl Med. 2009 Jan;34(1):4-6
references: 19092372
references: J Clin Endocrinol Metab. 1989 Jul;69(1):186-90
references: 2499590
references: Br J Cancer. 1997;75(5):734-9
references: 9043033
references: Thyroid. 2010 Jun;20(6):587-95
references: 20470203
references: Anticancer Res. 2009 May;29(5):1607-10
references: 19443373
references: Int J Cancer. 2005 Nov 1;117(2):281-8
references: 15880372
references: Eur J Nucl Med Mol Imaging. 2004 May;31(5):685-91
references: 14747959
references: Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1489-92
references: 18804919
references: Cancer. 2002 Nov 1;95(9):1869-78
references: 12404280
references: Int J Cancer. 2008 Oct 1;123(7):1681-4
references: 18623130
references: Surgery. 2007 Dec;142(6):806-13; discussion 813.e1-3
references: 18063060
references: Int J Cancer. 2010 Jun 15;126(12):2947-56
references: 19795465
references: Eur J Surg Oncol. 2001 Mar;27(2):157-61
references: 11289751
references: Br J Cancer. 2003 Nov 3;89(9):1638-44
references: 14583762
references: Head Neck. 2007 Jan;29(1):33-7
references: 16983696
references: Radiother Oncol. 2009 Nov;93(2):377-82
references: 19515442
references: Thyroid. 2009 Nov;19(11):1167-214
references: 19860577
references: Eur J Endocrinol. 2006 Dec;155(6):801-6
references: 17132748
references: J Clin Endocrinol Metab. 2001 Aug;86(8):3512-5
references: 11502772
references: J Clin Endocrinol Metab. 2008 Feb;93(2):504-15
references: 18029468
references: Br J Cancer. 2008 Mar 11;98(5):870-4
references: 18268495
references: Thyroid. 2009 May;19(5):451-7
references: 19281429
references: Radiother Oncol. 2008 Oct;89(1):97-104
references: 18534700
references: Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1543-9
references: 18559572
references: Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):24-33
references: 18722263